H Liu, J Mei, Y Xu, L Tang,
D Chen, Y Zhu… - International Journal …, 2019 - Taylor & Francis
Objective Nintedanib (NDNB) is a triple receptor tyrosine kinase inhibitor with poor solubility
in neutral conditions and low bioavailability. A self-microemulsifying drug delivery system …